Concepedia

Anna Cancella

AC

Statistics

Publications

2

Citations

162

H-Index

2

Active since

2002

Affiliations

Universidade Luterana do Brasil(Current)

Anna Cancella is an author at Universidade Luterana do Brasil specializing in cancer therapeutics, cancer research, and drug discovery.

Top concepts

Publications per year

2002–2006

2

Publications

2

Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix

Paula R. Pohlmann, Luciane Pons DiLeone, Anna Cancella et al. · American Journal of Clinical Oncology · 2002 · 86 citations

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

Gilberto Schwartsmann, Luciane Pons DiLeone, Marc E. Horowitz et al. · Investigational New Drugs · 2006 · 76 citations

, , +7

1–2 of 2